Unika Pharmaceuticals Private Limited

METROTREX 2.5 is a potent medication containing Methotrexate, an antimetabolite and antifolate drug used primarily to treat certain types of cancer, severe psoriasis, and rheumatoid arthritis. This medication works by interfering with the growth of rapidly dividing cells, making it effective in managing autoimmune diseases and certain cancers. METROTREX 2.5 provides a targeted approach to treatment, helping to alleviate symptoms and improve the quality of life for patients.

METROTREX 5 is a pharmaceutical tablet containing Methotrexate (5mg), a potent medication widely used to treat various medical conditions, including rheumatoid arthritis, psoriasis, and certain types of cancer. Methotrexate works by inhibiting the growth of rapidly dividing cells, making it effective for managing autoimmune disorders and malignancies. This medication is prescribed by healthcare professionals to help control disease activity and improve the quality of life for patients.

METROTREX 7.5 is a pharmaceutical medication containing Methotrexate, a potent disease-modifying antirheumatic drug (DMARD). It is primarily used to treat certain types of cancer, severe psoriasis, and rheumatoid arthritis. Methotrexate works by inhibiting the metabolism of folic acid, thus reducing the activity of the immune system and slowing the growth of cancer cells.

METROTREX 10 is a potent medication containing Methotrexate, a well-known disease-modifying antirheumatic drug (DMARD). This medication is primarily used to treat various autoimmune diseases and certain types of cancer. Methotrexate works by suppressing the immune system and inhibiting the growth of rapidly dividing cells, providing relief from symptoms and slowing disease progression.